Yahoo Web Search

  1. Yahoo Finance Results

  2. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices ...

  3. Investors in Valeant Pharmaceuticals International, Inc. VRX need to pay close attention to the stock based on moves in the options market lately. Options with high ...

    16.10-0.63 (-3.77%)

    at Mon, Mar 19, 2018, 13:30PM EST - U.S. Markets close in 1 hr 30 mins

    Nasdaq Real Time Price

    • Open 16.61
    • High 16.78
    • Low 16.09
    • Prev. Close 16.73
    • 52 Wk. High 8.31
    • 52 Wk. Low 8.31
    • P/E 2.36
    • Mkt. Cap 5.61B
  4. Shares of Valeant Pharmaceuticals Inc. VRX tumbled 9.2% after the company reported disappointed results for the fourth-quarter results on Feb 28. The company’s adjusted ...

  5. How Valeant Finally Won Over A Longtime Bear

    Benzinga via Yahoo FinanceMar 05 15:34 PM

    Valeant Pharmaceuticals Intl Inc (NYSE: VRX) fell 20 percent after reporting in-line earnings results. But the very news that catalyzed a selloff was well-received by one ...

  6. Valeant Tumbles on Declining Full-Year Revenues via Yahoo FinanceFeb 28 17:49 PM

    The Quebec-based company reported revenues of $8.724 billion for the year, down $950 million from the prior year. Fourth-quarter revenues of $2.163 billion underperformed analyst estimates by approximately $70 million. Warning!

  7. Stocks- U.S. Futures Inch Up Ahead of GDP Data via Yahoo FinanceFeb 28 13:42 PM – U.S. Futures pointed to a cautious opening bell on Wednesday as investors digest comments from Federal Reserve Chair Jerome Powell and look ahead to data.The S&P 500 futures ...

  8. Aerie's (AERI) Q4 Loss Wider on Higher Operating Expenses

    Zacks via Yahoo FinanceMar 01 14:32 PM

    Aerie Pharmaceuticals, Inc. AERI posted fourth-quarter 2017 loss of $1.38 per share, wider than the Zacks Consensus Estimate of a loss of $1.29 and the year-ago loss of 72 cents ...

  9. Valeant Nixes CEO's $29.8 Million Stock Award in Pay Overhaul

    Bloomberg via Yahoo FinanceMar 12 15:01 PM

    Valeant Pharmaceuticals International Inc. plans to kill a $29.8 million stock award it gave Chief Executive Officer Joseph Papa as the company revamps its compensation ...

  10. Five Things You Need to Know to Start Your Day

    Bloomberg via Yahoo FinanceFeb 28 11:29 AM

    The S&P 500 Index finished yesterday’s session 1.3 percent lower, its biggest decline in more than two weeks, after testimony from Federal Reserve Chair Jerome Powell in Congress was viewed ...

  11. Edited Transcript of VRX.TO earnings conference call or presentation 28-Feb-18 1:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceMar 01 4:51 AM

    Excluding divested assets and the impact of LOEs, our B + L/International segment and our Salix unit are expected to generate solid mid-single-digit revenue growth. Our dermatology business ...